Strongyloidiasis Clinical Trial
Official title:
Randomized, Open-label, Multi Centre Phase III Clinical Trial on Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
Ivermectin is currently the best drug to cure strongyloidiasis, but the "standard" single
dose of 200 mcg/kg is probably not enough to guarantee cure. As strongyloidiasis can be fatal
in immunosuppressed patients, it is mandatory to define the optimal dosage to eradicate the
parasite.
Aim of this study is to define the most effective dose schedule of ivermectin to cure
strongyloidiasis.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04999774 -
Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study
|
||
| Recruiting |
NCT05868005 -
Delivering a Multi-disease Screening Tool to Migrant Populations
|
N/A | |
| Completed |
NCT03676140 -
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
|
Phase 3 | |
| Recruiting |
NCT04844905 -
Adjunctive Ivermectin Mass Drug Administration for Malaria Control
|
Phase 3 | |
| Terminated |
NCT03605758 -
Treatment of Strongyloides Infection
|
Phase 3 | |
| Not yet recruiting |
NCT06373835 -
Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis
|
Phase 2 | |
| Completed |
NCT02105714 -
Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
|
N/A | |
| Not yet recruiting |
NCT04709848 -
Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK
|
||
| Completed |
NCT00207753 -
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections
|
N/A | |
| Completed |
NCT00001245 -
Study of Patients With Strongyloides Stercoralis Infection
|
N/A |